NCT06975852 Follow-Up Study on Children Exposed to Trauma
| NCT ID | NCT06975852 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul University |
| Condition | Post-traumatic Stress Disorder (PTSD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 210 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2025-07-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 210 participants in total. It began in 2025-02-17 with a primary completion date of 2025-07-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As far as it is known, there is no longitudinal study in Turkey investigating the follow-up and treatment of children and adolescents exposed to trauma. This study is planned to reassess children and adolescents with trauma exposure who were evaluated in Istanbul Faculty of Medicine Child Psychiatry outpatient clinic as part of a thesis study one year ago (January-April 2024) and to examine how many of them continue to meet the criteria for Post-Traumatic Stress Disorder (PTSD), how many receive a diagnosis of Complex Post-Traumatic Stress Disorder (CPTSD), and which factors are associated with these outcomes. In this way, it is aimed to contribute to the literature on the long-term effects of trauma exposure. Additionally, since there is no scale in our country that assesses the diagnosis of CPTSD in children, the study also aims to translate the Child and Adolescent Trauma Screen Scale - 2 (CATS-2) into Turkish and examine its psychometric properties.
Eligibility Criteria
Inclusion Criteria: * Children-adolescents who were exposed to at least one traumatic event and who were evaluated within the scope of the thesis study one year ago (January-April 2024), * Children and adolescents aged 7-18, * Children and/or parents with adequate literacy and Turkish language skills. Exclusion Criteria: * The presence of psychotic/manic symptoms in the child or parent during the interview or any condition that makes the interview and assessment impossible (e.g., mental or developmental condition or a different communication language), * The child or parent refusing to participate in the study, * The presence of autism spectrum disorder or intellectual disability at a severity that prevents assessment.
Contact & Investigator
Abdurrahman C Orengul, Associate Professor
PRINCIPAL INVESTIGATOR
Istanbul Faculty of Medicine, Child and Adolescent Psychiatry Department
Frequently Asked Questions
Who can join the NCT06975852 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 18 Years, studying Post-traumatic Stress Disorder (PTSD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06975852 currently recruiting?
Yes, NCT06975852 is actively recruiting participants. Contact the research team at beyzakaral@istanbul.edu.tr for enrollment information.
Where is the NCT06975852 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06975852 clinical trial?
NCT06975852 is sponsored by Istanbul University. The principal investigator is Abdurrahman C Orengul, Associate Professor at Istanbul Faculty of Medicine, Child and Adolescent Psychiatry Department. The trial plans to enroll 210 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.